Sabinsa Corporation granted patent for Tetrahydrocurcuminoids

Newsletters - August 2003

: 01 September 2003

US Patent # 6,653,327 titled “Cross-regulin composition of tumeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays” was granted to Sabinsa Corporation on November 25, 2003.

The patent describes a mixture of tetrahydrocurcuminoids which can be used for regulating random, intracellular protein cross-linking and to optimize cell electric potential. The composition can be orally, parenterally or topically administered to obtain the desired nutraceutical and cosmeceutical benefits.

VISIT US

Sabinsa Europe GmbH
Monzastrasse 4
63225 Langen
Germany

+49 6103 270 11 11
+49 6103 270 11 27
info@sabinsa.eu

CERTIFICATES

GLOBAL OFFICES

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.